Psychemedics Corp. (NASDAQ:PMD)

CAPS Rating: 3 out of 5

The Company provides testing services for the detection of abused substances through the analysis of hair samples by utilizing a patented technology to perform radioimmunoassays on enzymatically dissolved hair samples.

Results 1 - 6 of 6

Recs

0
Member Avatar TerryHoodSr (51.53) Submitted: 7/29/2013 11:08:25 PM : Outperform Start Price: $14.72 PMD Score: -16.76

potential

Recs

1
Member Avatar JTMcGee (37.91) Submitted: 11/5/2011 2:12:34 PM : Outperform Start Price: $8.06 PMD Score: +17.88

Current sales are not at all indicative of this company's potential.

They sell drug testing kits. Drug tests sell best during periods of rapid hiring, which we haven't seen in years. YET, this company keeps spewing dividends and generating FCF.

Downside is extremely limited, upside is almost unlimited. Easy call; great company.

Recs

0
Member Avatar mjmay9 (< 20) Submitted: 3/2/2011 6:18:19 PM : Outperform Start Price: $7.23 PMD Score: +46.36

Cash, management and historical performance. Good value here.

Recs

0
Member Avatar bdbartle1 (98.03) Submitted: 7/31/2007 2:43:43 PM : Outperform Start Price: $15.29 PMD Score: -49.30

High 5yr dividend Growth Rate
High ROE
No Debt

Recs

0
Member Avatar SilentOperator (73.54) Submitted: 7/15/2007 5:16:20 PM : Outperform Start Price: $15.47 PMD Score: -42.84

As long as drugs are illegal, this company will be making money.

Small Cap with large insider ownership, pays dividend.

Recs

0
Member Avatar majakblue (< 20) Submitted: 7/13/2007 9:57:31 PM : Outperform Start Price: $15.47 PMD Score: -42.84

Good IP, they hold the patent for drug testing using hair. Good customer base and they are slowly growing. I see potential. It is somewhat overpriced but not severely so. Long-term hold.

Results 1 - 6 of 6

Featured Broker Partners


Advertisement